Rollins School of Public Health | Faculty Profile
Emory Rollins School of Public Health

Farhad  Islami

Adjunct Associate Professor

Adjunct or Visiting, Epidemiology

As Scientific Director, Farhad Islami, MD, PhD, leads the Cancer Disparity Research team in the Data Science research group at the American Cancer Society (ACS). He primarily conducts transdisciplinary research to identify individual, social, biological, structural, and system level determinants of health and to estimate the contribution of each to cancer disparities. The objective of this work is to inform cancer care delivery and public policy. He also conducts and collaborates on research focused on cancer surveillance and risk factors.

Areas of Interest

  • Cancer Prevention
  • Epidemiology
  • Health Disparities

Affiliations & Activities

Islami’s research focuses on quantifying the impact of factors that contribute to cancer disparities across the cancer continuum. He has also conducted extensive research on the risk factors of cancer that are potentially modifiable.

As a member of the International Agency for Research on Cancer (IARC) team, Islami has been in multiple IARC Monographs and Handbooks and an IARC Monograph Working Group Member for Monograph volume 116, Carcinogenicity of Drinking Coffee, Mate, and Very Hot Beverages.
 

Full publication list:

Google Scholar

Publications

  • , , The changing landscape of cancer in the USA — Opportunities for advancing prevention and treatment, Nature Reviews Clinical Oncology, 17, 631-649
  • , , National and state estimates of lost earnings from cancer deaths in the United States, JAMA Oncology, 5, e191460
  • , , Proportion of cancer cases attributable to excess body weight by US state, 2011-2015, JAMA Oncology, 5, 384-392
  • , , Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States, Preventive Medicine, 123, 316-323
  • , , Incidence trends of esophageal and gastric cancer subtypes by race, ethnicity, and age in the United States, 1997-2014, Clinical Gastroenterology & Hepatology, 17, 429-439
  • , , Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, CA—A Cancer Journal for Clinicians, 68, 31-54